Albert Bourla - Pfizer Insider

Pfizer Inc -- USA Stock  

USD 35.50  0.010000  0.030000%

Group President - Vaccines, Oncology and Consumer Healthcare Business

Mr. Albert Bourla is Group President Pfizer Innovative Health of the company. He was Group President, Global Innovative Pharma Business from February 2016 until June 2016 and Group President, Vaccines, Oncology and Consumer Healthcare since January 2014. President and General Manager of Established Products Business Unit from December 2010 until December 2013. Area President Europe, Africa, Asia and Pacific of Pfizer Animal Health from 2009 until November 2010. Area President Europe, Africa and Middle East of Pfizer Animal Health from 2005 until 2009.
Age: 54  President Since 2016      
212 733-2323  www.pfizer.com

Albert Bourla Latest Insider Activity

Management Efficiency

The company has Return on Asset of 5.27 % which means that on every $100 spent on asset it made $5.27 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 13.68 % implying that it generated $13.68 on every 100 dollars invested.
The company has 43.87 B in debt with debt to equity (D/E) ratio of 74.7 . This implies that the company may be unable to create cash to meet all of its financial commitments. Pfizer Inc has Current Ratio of 1.31 which is typical for the industry and considered as normal.

Similar Executives

Showing few of many executives

PRESIDENT Since

Murthy SimhambhatlaAbbott Laboratories
2013
Joseph ManningAbbott Laboratories
2017
Michael CrowleyBio Rad Laboratories Inc
2014
Amit SachdevVertex Pharmaceuticals Incorpor
2017
Robert FunckAbbott Laboratories
2013
Ronald HuttonBio Rad Laboratories Inc
2012
Deepak NathAbbott Laboratories
2015
Camille FarhatEndo International plc
2012
Antonio PeraEndo International plc
2016
J WhiteAbbott Laboratories
2013
Michael PartridgeVertex Pharmaceuticals Incorpor
N/A
Roger BirdAbbott Laboratories
2015
Paul SilvaVertex Pharmaceuticals Incorpor
2011
Jonathon KellermanAllergan plc
2014
Jaime ContrerasAbbott Laboratories
2013
Thomas FrinziAbbott Laboratories
2016
Eric FainAbbott Laboratories
2017
Daniel SalvadoriAbbott Laboratories
2014
Michael McDonnellQuintiles IMS Holdings Inc
2015
Brian LortieEndo International plc
N/A
Michael PariniVertex Pharmaceuticals Incorpor
2017

Entity Summary

Pfizer Inc. discovers, develops, manufactures, and sells healthcare solutions worldwide. Pfizer Inc (PFE) is traded on New York Stock Exchange in USA. It is located in NEW YORK, U.S.A and employs 97,900 people. Pfizer is listed under Pharmaceutical Products category by Fama And French industry classification.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Pfizer Inc to your portfolio

Top Management

Pfizer Inc Leadership Team
John Young, President
Frank DAmelio, CFO
Douglas Lankler, President
Helen Hobbs, Director, Ph.D
Shantanu Narayen, Director
James Smith, Director
Dennis Ausiello, Director, Ph.D
Mikael Dolsten, President, Ph.D
Frances Fergusson, Director, Ph.D
Stephen Sanger, Director
Suzanne Johnson, Director
Alexander Mackenzie, President
Geno Germano, President
Laurie Olson, President
Sally Susman, President
Anthony Maddaluna, President
Freda LewisHall, President
Rady Johnson, President
W Cornwell, Director
Ian Read, Chairman
James Kilts, Director
Don Cornwell, Director
Charles Hill, President
Joseph Echevarria, Director
Albert Bourla, President
Kirsten LundJurgensen, President
Ronald Blaylock, Director
Kathrin Jansen, President, Ph.D

Stock Performance

Pfizer Performance Indicators